ArticleBioengineering (Basel, Switzerland)2022

Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins.

Seçkin Akgül et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.